This study evaluated the effect of a multiple sclerosis disease therapy management program on medication adherence, therapy persistence, relapses, work productivity, and quality of life. : To examine ...

Since the advent of the first multiple sclerosis (MS) disease-modifying therapy (DMT) almost 30 years ago, the range of treatments has significantly expanded. With many DMT options available and more ...

During MS Awareness Month, a Groundbreaking Research-and-Care Model Looks Back on 20 Years of Firsts I am eager to see ...

A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...

Multiple sclerosis (MS) is an insidious disease. Patients suffer because their immune system is attacking their own nerve fibres, which inhibits the transmission of nerve signals. People with MS ...

Keeping up with scientific advances and practice changes can be one the biggest challenges in managing a complex disease like multiple sclerosis (MS). The Consortium of Multiple Sclerosis Centers ...

Reviewed by Christopher Gharibo, MD, Medical Director of Pain Medicine, NYU Langone Hospitals Center, New York, NY Patients with multiple sclerosis (MS) are at a significantly increased risk for the ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. The ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

Share on Pinterest Although the reasons why a higher BMI might lead to increased MS risk are not fully understood, most scientists think that being obese increases overall inflammation in the body.